151 related articles for article (PubMed ID: 23912821)
1. Ifosfamide induced renal rickets.
Lionel AP; Chinnaswamy G; John RR; Mathai S
Indian J Pediatr; 2014 Sep; 81(9):943-5. PubMed ID: 23912821
[TBL] [Abstract][Full Text] [Related]
2. Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child.
Ashraf MS; Skinner R; English MW; Craft AW; Pearson AD
Med Pediatr Oncol; 1997 Jan; 28(1):62-4. PubMed ID: 8950339
[TBL] [Abstract][Full Text] [Related]
3. Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas.
Marina NM; Poquette CA; Cain AM; Jones D; Pratt CB; Meyer WH
J Pediatr Hematol Oncol; 2000; 22(2):112-8. PubMed ID: 10779023
[TBL] [Abstract][Full Text] [Related]
4. Karyomegalic-like nephropathy, Ewing's sarcoma and ifosfamide therapy.
McCulloch T; Prayle A; Lunn A; Watson AR
Pediatr Nephrol; 2011 Jul; 26(7):1163-6. PubMed ID: 21424282
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
[TBL] [Abstract][Full Text] [Related]
6. Hypophosphataemic rickets after ifosfamide treatment in children.
Sweeney LE
Clin Radiol; 1993 May; 47(5):345-7. PubMed ID: 8508598
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor.
Burk CD; Restaino I; Kaplan BS; Meadows AT
J Pediatr; 1990 Aug; 117(2 Pt 1):331-5. PubMed ID: 2166154
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide in pediatric solid tumors.
Carli M; Passone E; Perilongo G; Bisogno G
Oncology; 2003; 65 Suppl 2():99-104. PubMed ID: 14586158
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.
Stöhr W; Paulides M; Bielack S; Jürgens H; Treuner J; Rossi R; Langer T; Beck JD
Pediatr Blood Cancer; 2007 Apr; 48(4):447-52. PubMed ID: 16628552
[TBL] [Abstract][Full Text] [Related]
10. [Nephrotoxicity of ifosfamide with special reference to Fanconi Syndrome].
Rogowska E; Woźniak W
Med Wieku Rozwoj; 2004; 8(2 Pt 1):289-95. PubMed ID: 15738605
[TBL] [Abstract][Full Text] [Related]
11. Long-term evaluation of Ifosfamide-related nephrotoxicity in children.
Oberlin O; Fawaz O; Rey A; Niaudet P; Ridola V; Orbach D; Bergeron C; Defachelles AS; Gentet JC; Schmitt C; Rubie H; Munzer M; Plantaz D; Deville A; Minard V; Corradini N; Leverger G; de Vathaire F
J Clin Oncol; 2009 Nov; 27(32):5350-5. PubMed ID: 19826134
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of the accuracy and utility of early markers of Ifosfamide-induced proximal tubulopathy in survivors of childhood cancers.
Phillips RS; Tyerman K; Al-Kassim MI; Picton S
Pediatr Hematol Oncol; 2008 Mar; 25(2):107-13. PubMed ID: 18363176
[TBL] [Abstract][Full Text] [Related]
13. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.
Oberlin O; Habrand JL; Zucker JM; Brunat-Mentigny M; Terrier-Lacombe MJ; Dubousset J; Gentet JC; Schmitt C; Ponvert D; Carrié C
J Clin Oncol; 1992 Sep; 10(9):1407-12. PubMed ID: 1517783
[TBL] [Abstract][Full Text] [Related]
14. Ewing sarcoma/primitive neuroectodermal tumor of the kidney treated with chemotherapy including ifosfamide.
Yoshihara H; Kamiya T; Hosoya Y; Hasegawa D; Ogawa C; Asanuma H; Mizuno R; Hosoya R; Manabe A
Pediatr Int; 2016 Aug; 58(8):766-9. PubMed ID: 27324740
[TBL] [Abstract][Full Text] [Related]
15. Marriage and fertility in long-term survivors of childhood, adolescent and young adult (AYA) high-grade sarcoma.
Yonemoto T; Takahashi M; Maru M; Tomioka A; Saito M; Araki Y; Tazaki M; Tsuchiya M; Iwata S; Kamoda H; Ishii T
Int J Clin Oncol; 2016 Aug; 21(4):801-807. PubMed ID: 26792434
[TBL] [Abstract][Full Text] [Related]
16. [Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center].
Roguin A; Ben Arush MW; Higasi A; Kuten A
Harefuah; 1996 Apr; 130(8):511-4, 584. PubMed ID: 8765870
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
Meyer WH; Kun L; Marina N; Roberson P; Parham D; Rao B; Fletcher B; Pratt CB
J Clin Oncol; 1992 Nov; 10(11):1737-42. PubMed ID: 1403056
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide nephrotoxicity in paediatric cancer patients.
Ashraf MS; Brady J; Breatnach F; Deasy PF; O'Meara A
Eur J Pediatr; 1994 Feb; 153(2):90-4. PubMed ID: 8157032
[TBL] [Abstract][Full Text] [Related]
19. Painful peripheral neuropathy after treatment with high-dose ifosfamide.
Frisk P; Stålberg E; Strömberg B; Jakobson A
Med Pediatr Oncol; 2001 Oct; 37(4):379-82. PubMed ID: 11568902
[TBL] [Abstract][Full Text] [Related]
20. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults.
Ho PT; Zimmerman K; Wexler LH; Blaney S; Jarosinski P; Weaver-McClure L; Izraeli S; Balis FM
Cancer; 1995 Dec; 76(12):2557-64. PubMed ID: 8625085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
